TrialBMC neurology2015

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.

Mercedes P Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.